The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2025

Filed:

Aug. 03, 2022
Applicant:

The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);

Inventors:

Kenichi Hanada, Bethesda, MD (US);

Qiong J. Wang, Highland Park, NJ (US);

James C. Yang, Bethesda, MD (US);

Zhiya Yu, Potomac, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/26 (2005.12); A61K 39/00 (2005.12); A61P 35/00 (2005.12); A61P 35/04 (2005.12); C07K 14/725 (2005.12); A61K 38/00 (2005.12);
U.S. Cl.
CPC ...
C07K 16/26 (2012.12); A61K 39/001144 (2018.07); A61P 35/00 (2017.12); A61P 35/04 (2017.12); C07K 14/7051 (2012.12); A61K 38/00 (2012.12); A61K 2039/5156 (2012.12); C07K 2317/34 (2012.12); C07K 2317/565 (2012.12); C07K 2318/20 (2012.12); C07K 2319/00 (2012.12);
Abstract

Disclosed is a synthetic T cell receptor (TCR) having antigenic specificity for an HLA-A2-restricted epitope of thyroglobulin (TG), TG. Related polypeptides and proteins, as well as related nucleic acids, recombinant expression vectors, host cells, and populations of cells are also provided. Antibodies, or an antigen binding portion thereof, and pharmaceutical compositions relating to the TCRs of the invention are also provided. Also disclosed are methods of detecting the presence of cancer in a mammal and methods of treating or preventing cancer in a mammal.


Find Patent Forward Citations

Loading…